Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain
- PMID: 9063500
- DOI: 10.1111/j.1699-0463.1997.tb00538.x
Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain
Abstract
Hereditary cystatin C amyloid angiopathy (HCCAA), an autosomal dominant form of cerebral amyloid angiopathy (CAA) occurring primarily in Iceland, is characterized by a variant cystatin C amyloid deposition in the walls of cerebral parenchymal and leptomeningeal vessels. Cystatin C is also found to colocalize with amyloid beta/A4 protein in cerebral vessel walls of patients with Alzheimer's disease (AD), sporadic CAA, and hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). The abundance of cystatin C deposition in cerebral blood vessel walls suggests that cellular elements of the vessel wall itself may play a role in its deposition. Microvascular changes in the brains of HCCAA patients were investigated by single- and double-label immunohistochemistry. We found that cystatin C amyloid immunoreactivity was present not only in cerebral cortical and leptomeningeal vessels, but also in white matter parenchymal vessels. Cystatin C deposition was more prominent in the media of parenchymal vessels and in the adventitia of leptomeningeal vessels. Smooth muscle (sm) cells were few or could not be identified within vessel walls showing extensive cystatin C deposition, suggesting progressive loss of these cells as cystatin C accumulates. However, in less severely affected vessels, cystatin C was present in cells that also had the phenotype of sm, suggesting that sm cells synthesize or process cystatin C. Cystatin C immunoreactivity was in addition, detected in some neuronal cell bodies throughout the cortex in patients with HCCAA and AD-related CAA. Our results indicate that cellular components of the vessel walls may play an important role in cystatin C deposition, as they do in beta/A4 deposition in AD-related CAA. Cystatin C deposition within the vascular media and adventitia, with associated vessel wall injury as manifested by sm cell loss, represents microvascular degeneration that leads to cerebral hemorrhage.
Similar articles
-
Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.Am J Pathol. 1990 Aug;137(2):233-40. Am J Pathol. 1990. PMID: 2201197 Free PMC article.
-
Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D).Acta Neuropathol. 1998 Mar;95(3):235-44. doi: 10.1007/s004010050793. Acta Neuropathol. 1998. PMID: 9542588
-
Co-localization of beta/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis.Acta Neurol Scand. 1994 May;89(5):367-71. doi: 10.1111/j.1600-0404.1994.tb02648.x. Acta Neurol Scand. 1994. PMID: 8085435
-
Cerebral amyloid angiopathy and dementia.Panminerva Med. 2004 Dec;46(4):253-64. Panminerva Med. 2004. PMID: 15876981 Review.
-
The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models.Brain Pathol. 2006 Jan;16(1):60-70. doi: 10.1111/j.1750-3639.2006.tb00562.x. Brain Pathol. 2006. PMID: 16612983 Free PMC article. Review.
Cited by
-
Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression.PLoS One. 2017 Sep 14;12(9):e0184999. doi: 10.1371/journal.pone.0184999. eCollection 2017. PLoS One. 2017. PMID: 28910415 Free PMC article.
-
Serum cystatin C and the risk of Alzheimer disease in elderly men.Neurology. 2008 Sep 30;71(14):1072-9. doi: 10.1212/01.wnl.0000326894.40353.93. Neurology. 2008. PMID: 18824671 Free PMC article.
-
The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy.Int J Mol Sci. 2019 Dec 14;20(24):6319. doi: 10.3390/ijms20246319. Int J Mol Sci. 2019. PMID: 31847365 Free PMC article. Review.
-
Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.Lab Invest. 2017 Apr;97(4):383-394. doi: 10.1038/labinvest.2016.133. Epub 2017 Jan 9. Lab Invest. 2017. PMID: 28067897
-
Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects.Brain Pathol. 2006 Jan;16(1):55-9. doi: 10.1111/j.1750-3639.2006.tb00561.x. Brain Pathol. 2006. PMID: 16612982 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous